In this episode, Ben Pais, Senior Vice President at Ariceum Therapeutics, discusses innovative cancer treatments. His company develops drugs that use radiation to combat cancer.

He explains their strategies and adjustments in medical technology, focusing on radiotherapy.

He talks about the challenges of producing and distributing these drugs and the importance of having capable leaders.

Ben also explores future developments in this field and how large pharmaceutical companies acquiring smaller ones can impact the industry.

Here's what you are in for:

00:22 Moving from Clinical Medicine to Pharma

02:00 Starting Out from Surgery to Pharma

04:33 Discovering New Areas in Pharma

08:50 Getting into Radiopharmaceuticals

16:02 Growing in a Radiopharmaceutical Career

19:25 Understanding Radiopharmaceuticals: Simple to Complex

24:34 Finding Your Way in the Radiopharmaceutical Field

33:57 What's Next for Radiopharmaceuticals and Career Tips

About Ben Pais

Ben is a doctor with 25 years in the life science field. He knows about urology, cardiology, and radiation oncology. He has handled clinical trials (phase I-IV), medical affairs, drug safety, getting products to market, launching products, and early sales steps. Since 2019, he's been a certified Pharmaceutical Physician NVFG. In 2020, he started at Ipsen as the Global Development Lead for Radiopharmaceuticals. Later, he moved to Ariceum.

About Charles

Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.

He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.

Connect with Charles:

LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/

Website: https://discera-search.circle.so/

In this episode, Charles talks about how to craft authentic and genuine stories that can sell yourself and stand out from the rest. He points out that many resumes lack persuasive pitches and unique stories, so he offers 5 tips on creating these narratives. He stresses the need for authenticity and alignment with one's CV and interview responses.

He also discusses typical mistakes, like not showing the hidden benefits or linking past experiences to what future employers are looking for.

Here's what you are in for:

01:03 A Sneak Peek at Making Your CV

01:36 How to Make Sales Stories That Stick

04:18 Knowing Your Audience is Your First Step to Win

05:14 Being Specific on How to Make Stories Catchy

10:42 Using Lessons for Future Wins

11:26 The Secret to Job Applications

12:45 Building a Strong Professional Image

13:09 More Than Crafting a CV But Growing Your Career Chances

About Charles

Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.

He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.

Connect with Charles:

LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/

Website: https://discera-search.circle.so/

In this episode, Charles talks with Riccardo Canevari, the managing director and CEO of Radiopharm Theranostics, a company that is innovating the way we see cancer. They talked about his leadership journey in transitioning from leading 110k employees to a 3-man startup team. He also discusses launching innovative cancer treatments such as Luziterra and BluVicto and the challenges of selling them. He also highlights the importance of mission-driven work in biotech and the promise of radiopharmaceuticals in cancer treatment.

Here's what you are in for:

00:00 Ricardo's Journey From Milan to Pharma Leader

00:19 Family's Influence in Early Life

03:25 Ricardo's Career Path from Chemistry to Pharma

05:38 Highs and Lows in Pharma Industry

05:51 Leadership Lessons

10:27 Taking the new role as the head of Radio Pharm

17:59 Building a 3-man start up team

30:24 Reflecting on Leadership and Advancement

35:41 The Future of Radiotherapy

About Riccardo Canevari

Riccardo is an experienced leader in specialty pharma, cancer care, and radiopharmaceuticals. He served as the Chief Commercial Officer at Advanced Accelerator Applications, a leading company owned by Novartis. There, he led commercial strategies in around 20 countries. His main focus was on expanding the market for Lutathera and preparing for the launch of Lu-PSMA 617 to treat advanced prostate cancer. Before this, Riccardo held top positions at Novartis Oncology. He oversaw the successful introduction of breast cancer drugs like KISQALI and PIQRAY. He also gained extensive experience from different roles at Novartis Pharma and Ethicon/Johnson & Johnson.

Connect with Riccardo:

LinkedIn: https://www.linkedin.com/in/riccardo-canevari-7239931/

Website: https://www.radiopharmtheranostics.com/

About Charles

Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.

He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the

biggest talent needs of Early clinical stage SME biotechs on the East Coast and DACH.

Connect with Charles:

LinkedIn:https://www.linkedin.com/in/charles-spence-clinical/

Website:https://discera-search.circle.so/